Latest news

Hide mandatory notifications of trade

Mandatory notification of trade

Oslo 27.09.2012 - CEO of Bionor Pharma ASA, Steen Krøyer, has yesterdaypurchased 100,000 Bionor shares at a price of NOK 3.58 per share.

The shares are held through a nominee account in Nordea Luxembourg.

Steen Krøyer's holding after the purchase is 367,200 Bionor shares.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.